Lombard Odier Asset Management (USA)’s Repros Therapeutics Inc. RPRX Stock Holding History

Lombard Odier Asset Management (USA)’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-450,000	Closed	-$7.79M	–	283
2014 Q2	$7.79M	Sell	450,000 -150,000	-25%	-$2.45M	0.41%	64
2014 Q1	$10.6M	Hold	600,000	–	–	0.41%	71
2013 Q4	$11M	Buy	600,000 +250,000	+71%	+$4.72M	0.47%	71
2013 Q3	$9.38M	Sell	350,000 -215,000	-38%	-$4.61M	0.47%	54
2013 Q2	$10.4M	Buy	+565,000	New	+$9.98M	0.58%	64

Other funds holding RPRX

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

DCM

Destrier Capital Management New York $144M AUM 7.28% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BIM

Bogle Investment Management Newton Lower Falls, Massachusetts $63M AUM 51.97% 1-Year Est. Return

Lombard Odier Asset Management (USA)'s RPRX Position: Q3 2014 in Review

Lombard Odier Asset Management (USA) sold out of Repros Therapeutics Inc. (RPRX) in Q3 2014, closing a stake of 450,000 shares — an estimated $7.79M sold.

Lombard Odier Asset Management (USA) first reported a position in RPRX in Q2 2013 and held it in 5 quarters. The position peaked at $11M in Q4 2013. 75 funds tracked by Wall St. Rank hold RPRX as of Q3 2014.

Lombard Odier Asset Management (USA) reported no remaining Repros Therapeutics Inc. position as of Q3 2014 after selling out during the quarter.
Lombard Odier Asset Management (USA) sold 450,000 Repros Therapeutics Inc. shares in Q3 2014, an estimated $7.79M.
Lombard Odier Asset Management (USA) first reported a position in Repros Therapeutics Inc. in Q2 2013 and held it in 5 quarters.
Lombard Odier Asset Management (USA)'s Repros Therapeutics Inc. position peaked at $11M in Q4 2013.
75 funds tracked by Wall St. Rank held Repros Therapeutics Inc. as of Q3 2014.

Based on Lombard Odier Asset Management (USA)'s 13F filing for Q3 2014, filed 14 Nov 2014.